SVRA

Savara Inc.

Insider Trades

NameValueActionPriceCurrent Price
Ramsay David ADirector
$121k20k shares
SellDec 19, 2025
$6.06
--
Hawkins Richard JDirector
$99k48.2k shares
BuyJun 20, 2025
$2.04
--
McCracken Joseph SDirector
$21k10k shares
BuyMay 29, 2025
$2.08
--
Ramsay David ADirector
$416k150k shares
BuyMar 31, 2025
$2.78
--
Pauls MatthewDirector, Officer: CHIEF EXECUTIVE OFFICER
$181k54.7k shares
SellDec 16, 2024
$3.31
--
Lowrance David LChief Financial Officer
$83k25k shares
SellDec 16, 2024
$3.33
--

News

businesswire.comSavara Announces New Employment Inducement Grantbusinesswire.comJun 12businesswire.comSavara Announces Chief Financial and Administrative Officer Transitionbusinesswire.comJun 8businesswire.comSavara Announces Participation in the 2026 Jefferies Global Healthcare Conferencebusinesswire.comMay 27seekingalpha.comSavara: The Rare Disease Funnel Is Becoming A Commercial Assetseekingalpha.comMay 27gurufocus.comSavara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thorgurufocus.comMay 20